Waratah Capital Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,241
Closed -$1.11M 153
2019
Q3
$1.11M Buy
+5,241
New +$1.1M 0.12% 106
2018
Q3
Sell
-2,210
Closed -$362K 147
2018
Q2
$362K Buy
2,210
+820
+59% +$134K 0.04% 119
2018
Q1
$225K Buy
+1,390
New +$221K 0.02% 109
2017
Q1
Sell
-5,300
Closed -$611K 162
2016
Q4
$611K Buy
+5,300
New +$590K 0.09% 103

Other funds holding CME

Waratah Capital Advisors's CME Position: Q4 2019 in Review

Waratah Capital Advisors sold out of CME Group (CME) in Q4 2019, closing a stake of 5,241 shares — an estimated $1.11M sold.

Waratah Capital Advisors first reported a position in CME in Q4 2016 and held it in 4 quarters. The position peaked at $1.11M in Q3 2019. 1,060 funds tracked by Wall St. Rank hold CME as of Q4 2019.

  • Waratah Capital Advisors reported no remaining CME Group position as of Q4 2019 after selling out during the quarter.
  • Waratah Capital Advisors sold 5,241 CME Group shares in Q4 2019, an estimated $1.11M.
  • Waratah Capital Advisors first reported a position in CME Group in Q4 2016 and held it in 4 quarters.
  • Waratah Capital Advisors's CME Group position peaked at $1.11M in Q3 2019.
  • 1,060 funds tracked by Wall St. Rank held CME Group as of Q4 2019.

Based on Waratah Capital Advisors's 13F filing for Q4 2019, filed 13 Feb 2020.